1. Brown SM, Doom JR, Lechuga-Peña S, Watamura SE, Koppels T. Stress and parenting during the global COVID-19 pandemic. Child Abuse Negl. 2020; 110(Pt 2):104699. pmid: 32859394 doi: 10.1016/j.chiabu.2020.104699
2. Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun. 2020;89:531-542. pmid: 32485289 doi: 10.1016/j.bbi.2020.05.048
3. Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, et al. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open. 2020;3(3):e203976. pmid: 32202646 doi: 10.1001/jamanetworkopen.2020.3976
4. Islam MA, Barna SD, Raihan H, Khan MNA, Hossain MT. Depression and anxiety among university students during the COVID-19 pandemic in Bangladesh: A web-based cross-sectional survey. PLoS One. 2020;15(8):e0238162. pmid: 32845928 doi: 10.1371/journal.pone.0238162
5. La Rosa VL, Gori A, Faraci P, Vicario CM, Craparo G. Traumatic distress, alexithymia, dissociation, and risk of addiction during the first wave of COVID-19 in Italy: results from a cross-sectional online survey on a non-clinical adult sample. International Int J Ment Health Addict. 2022;20(5):3128-44. pmid: 34131416 doi: 10.1007/s11469-021-00569-0
6. Columb D, Hussain R, O’Gara C. Addiction psychiatry and COVID-19: Impact on patients and service provision. Ir J Psychol Med. 2020;37(3):164-8. pmid: 32434597 doi: 10.1017/ipm.2020.47
7. Meng L, Hua F, Bian Z. Coronavirus disease 2019 (COVID-19): emerging and future challenges for dental and oral medicine. J Dent Res. 2020;99(5):481-7. pmid: 32162995 doi: 10.1177/0022034520914246
8. Leshner AI. Drug abuse and addiction treatment research: the next generation. Arch Gen Psychiatry. 1997;54(8):691-4. pmid: 9283502 doi: 10.1001/archpsyc.1997.01830200015002
9. Liu J-f, Li J-x. Drug addiction: a curable mental disorder? Acta Pharmacol Sin. 2018;39(12):1823-9. pmid: 30382181 doi: 10.1038/s41401-018-0180-x
10. Mohammadi M, Kazeminia M, Abdoli N, Khaledipaveh B, Shohaimi S, Salari N, et al. The effect of methadone on depression among addicts: a systematic review and meta-analysis. Health Qual Life Outcomes. 2020;18(1): 373. pmid:
11. 33225933 doi: 10.1186/s12955-020-01599-3
12. Brothers S, Viera A, Heimer R. Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19. J Subst Abuse Treat. 2021;131:108449. pmid: 34098303 doi: 10.1016/j.jsat.2021.108449
13. Nolen-Hoeksema S. The role of rumination in depressive disorders and mixed anxiety/depressive symptoms.
14. J Abnorm Psychol. 2000;109(3):504-11. pmid: 11016119
15. Bushman BJ, Bonacci AM, Pedersen WC, Vasquez EA, Miller N. Chewing on it can chew you up: effects of rumination on triggered displaced aggression. J Pers Soc Psychol. 2005;88(6):969-83. pmid: 15982116 doi: 10.1037/0022-3514.88.6.969
16. Sher L. Post-COVID syndrome and suicide risk. QJM. 2021;114(2):95-8. pmid: 33486531 doi: 10.1093/qjmed/hcab007
17. Liu D, Baumeister RF, Veilleux JC, Chen C, Liu W, Yue Y, et al. Risk factors associated with mental illness in hospital discharged patients infected with COVID-19 in Wuhan, China. Psychiatry Res. 2020;292:113297. pmid: 32707218 doi: 10.1016/j.psychres.2020.113297
18. Torales J, O’Higgins M, Castaldelli-Maia JM, Ventriglio A. The outbreak of COVID-19 coronavirus and its impact on global mental health. Int J Soc Psychiatry. 2020; 66(4):317-20. pmid: 32233719 doi: 10.1177/0020764020915212
19. Einvik G, Dammen T, Ghanima W, Heir T, Stavem, K. Prevalence and Risk Factors for Post-Traumatic Stress in Hospitalized and Non-Hospitalized COVID-19 Patients. Int J Environ Res Public Health. 2021;18(4):2079. pmid: 33672759 doi: 10.3390/ijerph18042079
20. Tsamakis K, Tsiptsios D, Ouranidis A, Mueller C, Schizas D, Terniotis C, et al. COVID-19 and its consequences on mental health. Exp Ther Med. 2021;21(3):344. pmid: 33603852 doi: 10.3892/etm.2021.9675
21. Galal I, Hussein AAM, Amin MT, Saad MM, Zayan HEE, Abdelsayed MZ, et al. Determinants of persistent post-COVID-19 symptoms: value of a novel COVID-19 symptom score. Egypt J Bronchol. 2021;15(1):10. doi: 10.1186/s43168-020-00049-4
22. Mrklas K, Shalaby R, Hrabok M, Gusnowski A, Vuong W, Surood S, et al. Prevalence of perceived stress, anxiety, depression, and obsessive-compulsive symptoms in health care workers and other workers in alberta during the COVID-19 Pandemic: cross-sectional survey. JMIR Ment Health. 2020;7(9):e22408. pmid: 32915764 doi: 10.2196/22408
23. Watkins E, Scott J, Wingrove J, Rimes K, Bathurst N, Steiner H, et al. Rumination-focused cognitive behaviour therapy for residual depression: A case series. Behav Res Ther. 2007;45(9):2144-54. pmid: 17367751 doi: 10.1016/j.brat.2006.09.018
24. Aftab R, Meigouni AKM, Taghiloo S. The mediating role of emotion regulation strategies in the relationship between borderline personality and conjugal violence [in Persian].
25. J Appl Psychol. 2015;8(4):6-27.
26. Ghorbani F, Ghandi M, Yousefi N, Shokri Mojdeh M. Evaluation of COVID19 Pandemic Associated Anxiety and Stress Levels among Dental Students of Qazvin University of Medical Sciences, Spring 2020 [in Persian]. J Arak Uni Med Sci. 2023;25(6):50-57. doi: 10.61186/jams.25.6.50
27. Bagherinezhad M, Salehi Fadardi J, Tabatabayi SM. The relationship between rumination and depression in a sample of Iranian student [in Persian]. Research in Clinical Psychology and Counseling. 2010;011(1):21-38. doi: 10.22067/ijap.v11i1.6910
28. Buss AH, Perry M. The aggression questionnaire. J Pers Soc Psychol. 1992;63(3):452-9. pmid: 1403624 doi: 10.1037//0022-3514.63.3.452
29. Samani S. Study of Reliability and Validity of the Buss and
30. Perry's Aggression Questionnaire [in Persian]. Iranian Journal of Psychiatry and Clinical Psychology. 2008;13(4):359-65.
31. Liu X, Jin X, Zhang Y, Zhang L, Li Y, Ma J. Effect of Coronavirus disease 2019 on the psychology and behavior of patients on methadone maintenance treatment in wuhan, china: A clinical observational study. Front Psychiatry. 2021;12:653662. pmid: 33859585 doi: 10.3389/fpsyt.2021.653662
32. Amram O, Amiri S, Panwala V, Lutz R, Joudrey PJ, Socias E. The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era. Am J Drug Alcohol Abuse. 2021;47(6):722-9. pmid: 34670453 doi: 10.1080/00952990.2021.1979991
33. Farhoudian A, Baldacchino A, Clark N, Gerra G, Ekhtiari H, Dom G, et al. COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response. an international society of addiction medicine practice and policy interest group position paper. Basic Clin Neurosci. 2020;11(2):133-50. pmid: 32855772 doi: 10.32598/bcn.11.covid19.1
34. Marmarosh CL, Forsyth DR, Strauss B, Burlingame GM. The psychology of the COVID-19 pandemic: A group-level perspective. Group Dynamics: Theory, Research, and Practice. 2020;24(3):122-38.